Litigation Details for CELGENE CORPORATION v. HETERO LABS LIMITED (D.N.J. 2019)
✉ Email this page to a colleague
CELGENE CORPORATION v. HETERO LABS LIMITED (D.N.J. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-07-16 |
Court | District Court, D. New Jersey | Date Terminated | 2021-01-10 |
Cause | 15:1126 Patent Infringement | Assigned To | Susan Davis Wigenton |
Jury Demand | None | Referred To | Leda Dunn Wettre |
Parties | HETERO LABS LIMITED | ||
Patents | 7,189,740; 7,968,569; 8,404,717; 8,530,498; 8,648,095; 9,056,120; 9,101,621; 9,101,622 | ||
Attorneys | BRIAN JOHN FORSATZ | ||
Firms | Eric I. Abraham | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in CELGENE CORPORATION v. HETERO LABS LIMITED
Biologic Drugs cited in CELGENE CORPORATION v. HETERO LABS LIMITED
Details for CELGENE CORPORATION v. HETERO LABS LIMITED (D.N.J. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-07-16 | 1 | Complaint | United States Patent Nos. 7,189,740 (“the ’740 patent”), 7,968,569 (“the ’569 patent”), 8,404,717 (“…(“the ’717 patent”), 8,530,498 (“the ’498 patent”), 8,648,095 (“the ’095 patent”), 9,056,120 (“the ’120…’120 patent”), 9,101,621 (“the ’621 patent”), and 9,101,622 (“the ’622 patent”) (collectively, “the patents-in-suit… 1. This is an action for patent infringement under the patent laws of the United States, 35 U.S.C… The Patents-in-Suit 10. On March 13, 2007, the United States Patent and Trademark | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |